Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Investing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Investing Activities ₹-826 Cr₹-477 Cr₹-434 Cr₹-1,339 Cr₹-1,812 Cr

What is the latest Cash Flow from Investing Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Investing Activities ratio of PIRAMAL PHARMA is ₹-826 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Investing Activities
Mar2026₹-826 Cr
Mar2025₹-477 Cr
Mar2024₹-434 Cr
Mar2023₹-1,339 Cr
Mar2022₹-1,812 Cr

How is Cash Flow from Investing Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2026 ₹-826 Cr
Negative
Mar2025 ₹-477 Cr
Negative
Mar2024 ₹-434 Cr
Negative
Mar2023 ₹-1,339 Cr
Negative
Mar2022 ₹-1,812 Cr -

Compare Cash Flow from Investing Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,938.9 Cr -7.2% -1.2% 2.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -1.5% 15.1% Stock Analytics
DIVIS LABORATORIES ₹244,223.0 Cr -3% 8.3% 52.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹183,453.0 Cr -2.2% -1.5% 35% Stock Analytics
CIPLA ₹109,849.0 Cr -0.6% -4.9% -13% Stock Analytics
DR REDDYS LABORATORIES ₹95,591.8 Cr 0.2% -3.9% -11.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-7.2%

-1.2%

2.2%

SENSEX

-1.6%

-4.7%

-8.3%


You may also like the below Video Courses